{
    "Trade/Device Name(s)": [
        "Pool Norm Plasma",
        "Pool Norm"
    ],
    "Submitter Information": "Diagnostica Stago S.A.S.",
    "510(k) Number": "K142132",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061803"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGN"
    ],
    "Summary Letter Date": "November 4, 2014",
    "Summary Letter Received Date": "November 6, 2014",
    "Submission Date": "December 12, 2014",
    "Regulation Number(s)": [
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Multipurpose system for in vitro coagulation studies"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Activated partial thromboplastin time (APTT)",
        "Dilute Russell's viper venom time (dRVVT)"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "STA-R",
        "STA Compact",
        "STA Satellite"
    ],
    "Method(s)/Technology(ies)": [
        "Coagulation assay"
    ],
    "Methodologies": [
        "Coagulation time determination"
    ],
    "Submission Type(s)": [
        "Control",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Pool Norm Plasma lyophilized normal human plasma control for APTT and dRVVT coagulation assays.",
    "Indications for Use Summary": "Intended for use as a normal control in APTT and dRVVT assays performed on STA-R, STA Compact, and STA Satellite analyzers in clinical laboratories.",
    "fda_folder": "Hematology"
}